0000899243-22-007921.txt : 20220225
0000899243-22-007921.hdr.sgml : 20220225
20220225170813
ACCESSION NUMBER: 0000899243-22-007921
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220223
FILED AS OF DATE: 20220225
DATE AS OF CHANGE: 20220225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Patrick F.
CENTRAL INDEX KEY: 0001814771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39333
FILM NUMBER: 22681721
MAIL ADDRESS:
STREET 1: C/O FORMA THERAPEUTICS HOLDINGS, INC.
STREET 2: 500 ARSENAL STREET, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forma Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001538927
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 371657129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 NORTH BEACON STREET
STREET 2: SUITE 501
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-679-1970
MAIL ADDRESS:
STREET 1: 300 NORTH BEACON STREET
STREET 2: SUITE 501
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Forma Therapeutics Holdings, Inc.,
DATE OF NAME CHANGE: 20200331
FORMER COMPANY:
FORMER CONFORMED NAME: Forma Therapeutics Holdings LLC
DATE OF NAME CHANGE: 20120106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-23
0
0001538927
Forma Therapeutics Holdings, Inc.
FMTX
0001814771
Kelly Patrick F.
C/O FORMA THERAPEUTICS HOLDINGS, INC.
300 NORTH BEACON STREET, SUITE 501
WATERTOWN
MA
02472
0
1
0
0
SVP, Chief Medical Officer
Common Stock
2022-02-23
4
S
0
5245
9.7775
D
64884
D
Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The Form 4 filed by the reporting person on March 2, 2021 inadvertently understated the number of shares of Common Stock directly held by the reporting person by 42,959 shares.
/s/ Jeannette Potts, as Attorney-in-Fact
2022-02-25